Gene Editing
Overview
R&D Platforms
Manufacturing
Papers & Presentations
Our Pipeline
Our Pipeline
Ex Vivo Therapies
In Vivo Therapies
Targeted Therapies
Our Focus
Genetic Diseases
Cancer
About Us
Company Overview
Scientific Founder
Leadership
Contact Us
Careers
Join Us
News
Press Releases
In the Media
简体中文
中文
Genome Editing
for a Better Life
Learn More
Four Genome Editing Based Platforms
Learn More
Our Pipeline
Ex vivo and in vivo gene-editing therapies,
and targeted therapies
Learn More
Patient focused
Learn More
Genetic diseases
Cancer
News
Press Releases
EdiGene Announces Approval of its IND Application for its CRISPR/Cas 9 Gene-edit ...
Read More》
Press Releases
EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan
Read More》
Press Releases
EdiGene Announces IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia Accepted for Review by China National Medical Products Administration
Read More》
Press Releases
EdiGene Raises Approximately USD 67 Million in Series B Financing to Advance Gene Editing Based Programs into Clinical Stage
Read More》
In the Media
Application given for gene therapy trials to treat blood disease
CHINADAILY
Read More》